200 related articles for article (PubMed ID: 12032820)
1. Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Carlson H; Ota S; Song Y; Chen Y; Hurlin PJ
Oncogene; 2002 May; 21(24):3827-35. PubMed ID: 12032820
[TBL] [Abstract][Full Text] [Related]
2. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
3. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
4. Omomyc expression in skin prevents Myc-induced papillomatosis.
Soucek L; Nasi S; Evan GI
Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
[TBL] [Abstract][Full Text] [Related]
5. Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway.
Jerome-Majewska LA; Jenkins GP; Ernstoff E; Zindy F; Sherr CJ; Papaioannou VE
Dev Dyn; 2005 Dec; 234(4):922-33. PubMed ID: 16222716
[TBL] [Abstract][Full Text] [Related]
6. TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines.
Fan W; Huang X; Chen C; Gray J; Huang T
Cancer Res; 2004 Aug; 64(15):5132-9. PubMed ID: 15289316
[TBL] [Abstract][Full Text] [Related]
7. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
Hansen RS; Braithwaite AW
Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
[TBL] [Abstract][Full Text] [Related]
8. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
9. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc.
Han JW; Dionne CA; Kedersha NL; Goldmacher VS
Cancer Res; 1997 Jan; 57(1):176-82. PubMed ID: 8988061
[TBL] [Abstract][Full Text] [Related]
10. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
11. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
12. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
13. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
14. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
15. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
16. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
17. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
19. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
20. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
